Cargando…

Irisin as a Potential Biomarker Associated with Myocardial Injuries in Patients with Severe Hypothyroidism

OBJECTIVE: Irisin, a novel myokine, has recently been considered to produce a cardioprotective effect. Potential biomarkers for myocardial injuries in patients with severe hypothyroidism have yet to be identified. We aimed to investigate whether serum irisin may serve as a promising biomarker for ea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Zhi, Ding, Xiaoyu, Gao, Xia, Yang, Ning, Jia, Yumei, Liu, Jia, Wang, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616683/ https://www.ncbi.nlm.nih.gov/pubmed/34840567 http://dx.doi.org/10.1155/2021/3116068

Ejemplares similares

Role of irisin in Chinese patients with hypothyroidism: an interventional study
por: Yang, Ning, et al.
Publicado: (2019)

Native Magnetic Resonance T1-Mapping Identifies Diffuse Myocardial Injury in Hypothyroidism
por: Gao, Xia, et al.
Publicado: (2016)

Diffuse Myocardial Injuries are Present in Subclinical Hypothyroidism: A Clinical Study Using Myocardial T1-mapping Quantification
por: Yao, Zhi, et al.
Publicado: (2018)

PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia
por: Feng, Xiaomeng, et al.
Publicado: (2015)

Novel Clinical Evidence of an Association between Homocysteine and Insulin Resistance in Patients with Hypothyroidism or Subclinical Hypothyroidism
por: Yang, Ning, et al.
Publicado: (2015)

Potential harmful correlation between homocysteine and low-density lipoprotein cholesterol in patients with hypothyroidism
por: Dong, Xuejie, et al.
Publicado: (2016)

Homocysteine diminishes apolipoprotein A-I function and expression in patients with hypothyroidism: a cross-sectional study
por: Yang, Ning, et al.
Publicado: (2016)

Levothyroxine Replacement Alleviates Thyroid Destruction in Hypothyroid Patients With Autoimmune Thyroiditis: Evidence From a Thyroid MRI Study
por: Liu, Jia, et al.
Publicado: (2019)

Association of serum irisin concentration with thyroid autoantibody positivity and subclinical hypothyroidism
por: Chen, Zhengyi, et al.
Publicado: (2021)

Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism
por: Yasar, Hamiyet Yilmaz, et al.
Publicado: (2019)

Relation of kidney function and homocysteine in patients with hypothyroidism
por: Pan, Qingrong, et al.
Publicado: (2021)

Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity
por: Carmona-Maurici, Júlia, et al.
Publicado: (2023)

Irisin Attenuates Myocardial Ischemia/Reperfusion Injury and Improves Mitochondrial Function Through AMPK Pathway in Diabetic Mice
por: Xin, Chao, et al.
Publicado: (2020)

Serum irisin correlates to the severity of acute myocardial infarction and predicts the postoperative major adverse cardiovascular events
por: Chai, Qiaoying, et al.
Publicado: (2023)

Serum Irisin as a Potential Biomarker for Cognitive Decline in Vascular Dementia
por: Zhang, Feng, et al.
Publicado: (2021)

Thyroid hormones modulate irisin concentrations in patients with recently onset hypothyroidism following total thyroidectomy
por: Bocale, R., et al.
Publicado: (2020)

Irisin: A Promising Target for Ischemia-Reperfusion Injury Therapy
por: Wang, Yani, et al.
Publicado: (2021)

Irisin ameliorates myocardial ischemia-reperfusion injury by modulating gut microbiota and intestinal permeability in rats
por: Liu, Qingqing, et al.
Publicado: (2023)

Serum IL-27 levels increase in subjects with hypothyroidism and are negatively correlated with the occurrence of nonalcoholic fatty liver disease
por: Wen, Yahui, et al.
Publicado: (2023)

Serum irisin levels are decreased in patients with sepsis, and exogenous irisin suppresses ferroptosis in the liver of septic mice
por: Wei, Shasha, et al.
Publicado: (2020)

Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
por: Ho, Ming-Yun, et al.
Publicado: (2021)

Circulating Irisin Level as a Biomarker for Pure Aortic Stenosis and Aortic Valve Calcification
por: Wang, Shan-shan, et al.
Publicado: (2022)

Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2022)

Irisin Improves Autophagy of Aged Hepatocytes via Increasing Telomerase Activity in Liver Injury
por: Bi, Jianbin, et al.
Publicado: (2020)

Irisin is an Effector Molecule in Exercise Rehabilitation Following Myocardial Infarction (Review)
por: Qin, Shuguang, et al.
Publicado: (2022)

Role of irisin in physiology and pathology
por: Liu, Shiqiang, et al.
Publicado: (2022)

FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction
por: Deng, Jingyu, et al.
Publicado: (2020)

Association Between Serum Irisin Levels and ST-Segment Elevation Myocardial Infarction
por: Ozturk, Derya, et al.
Publicado: (2023)

Neuroprotective Effects of Exogenous Irisin in Kainic Acid-Induced Status Epilepticus
por: Cheng, Yao, et al.
Publicado: (2021)

273 Severe Hypothyroidism-Induced Rhabdomyolysis and Acute Kidney Injury
Publicado: (2020)

Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Wang, Qiu, et al.
Publicado: (2021)

Irisin Protects Against Hind Limb Ischemia Reperfusion Injury
por: Küçük, Ayşegül, et al.
Publicado: (2021)

Irisin a Novel Metabolic Biomarker: Present Knowledge and Future Directions
por: Martinez Munoz, Ilse Yessabel, et al.
Publicado: (2018)

Circulating Irisin and esRAGE as Early Biomarkers of Decline of Metabolic Health
por: Dozio, Elena, et al.
Publicado: (2020)

Irisin ERKs the Fat
por: Wu, Jun, et al.
Publicado: (2014)

Irisin in Liver Cirrhosis
por: Kukla, Michał, et al.
Publicado: (2020)

FNDC5/Irisin Inhibits the Inflammatory Response and Mediates the Aerobic Exercise-Induced Improvement of Liver Injury after Myocardial Infarction
por: Wang, Tao, et al.
Publicado: (2023)

The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels
por: Suna, Aydin, et al.
Publicado: (2017)

The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity
por: Li, Hui, et al.
Publicado: (2021)

Irisin: a new molecular marker and target in metabolic disorder
por: Chen, Jia-qi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_20e3gfbmfrh37lh4j0fr1dhtpk